Navigation Links
Novel biomarker approach suggests new avenues to improve schizophrenia disease management
Date:1/9/2014

Environmental effects of events such as oxygen deprivation and infections may be preserved as markers in blood that are associated to schizophrenia, according to an international study led by the Virginia Commonwealth University School of Pharmacy's Center for Biomarker Research and Personalized Medicine.

"These markers, possibly from as early as embryonic development or birth, could be of considerable clinical importance as they could allow for identification of distinct schizophrenia subtypes or help predict treatment responses," said Karolina Aberg, Ph.D., associate director of the Center for Biomarker Research and Personalized Medicine and first author of the study.

Schizophrenia is a devastating psychiatric disorder. Although there is strong support for the involvement of DNA sequence variation in the development of the disorder, other factors such as environmental influences are also likely to play a major role.

The research team performed one of the first large-scale, methylome-wide association studies (MWAS) of schizophrenia, as detailed online in the January issue of JAMA Psychiatry, the JAMA Network journal.

"Methylation is a specific modification to the DNA molecule that could potentially reflect environmental events," said Edwin van den Oord, Ph.D., director of the Center for Biomarker Research and Personalized Medicine and senior author of the study. "Therefore, DNA methylation studies are very promising complements to traditional genetic studies that potentially can give us a deeper understanding of the schizophrenia disease etiology."

In this study, researchers investigated approximately 27 million DNA methylation markings in blood samples from 1,497 schizophrenia cases and controls.

This methylome-wide screening was performed by extracting the methylated portion of the genome and then investigating this portion with massively parallel next-generation sequencing. To ensure that the findings from this screening were not false findings caused, for example, by method-specific artifacts or statistical errors, researchers used a different technology to follow up the critical top findings in independent subjects who were not part of the initial screening step.

The study identified 139 highly significant methylation sites. Many of the replicating markings could be linked to hypoxia, immune response and neuronal differentiation, which are risk factors previously associated with schizophrenia development.


'/>"/>

Contact: Eric Peters
petersem@vcu.edu
804-828-0563
Virginia Commonwealth University
Source:Eurekalert  

Related medicine news :

1. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
2. Rutgers team discovers novel approach to stimulate immune cells
3. Novel drug candidates offer new route to controlling inflammation
4. Researchers present new findings for novel pancreatic cancer vaccine
5. Novel biomarkers reveal evidence of radiation exposure
6. VCU Massey Cancer Center sees potential in novel leukemia treatment
7. Study supports urate protection against Parkinsons disease, hints at novel mechanism
8. Novel Natural Sciences Repository Opens Web Portal
9. Novel Anti-Inflammatories May Offer a New Approach for the Treatment of Stroke
10. LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
11. Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel biomarker approach suggests new avenues to improve schizophrenia disease management
(Date:10/13/2017)... AR (PRWEB) , ... October 13, 2017 , ... ... with locations throughout Arkansas that offers insurance and financial preparation services, is providing ... the Rock City Rescue organization. , Rock City Rescue is a locally recognized ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology: